
ViroMissile Appointed New Clinical and Strategic Advisors
The San Diego-based biotech firm added veteran expertise to support its ongoing Phase 1 oncolytic virus clinical trials.

The San Diego-based biotech firm added veteran expertise to support its ongoing Phase 1 oncolytic virus clinical trials.
October 6, 2026
Invivoscribe Launched New Oncology Sequencing SuiteThe platform helps research laboratories analyze gene rearrangements to improve the study of blood-based cancers.
September 28, 2026
Colorectal Cancer Trial Sites Have Opened for EnrollmentThe REO 033 study is now recruiting patients with metastatic colorectal cancer to test a new treatment combination.
September 28, 2026
New KRAS Inhibitor Showed Potential in Cancer ModelsResearchers in San Diego shared data on an experimental drug that targeted mutated proteins in pancreatic and other cancers.
September 24, 2026
Sharp Memorial Has Offered New Prostate Cancer TherapySan Diego residents with advanced prostate cancer now have access to targeted radiation treatments.